Methamphetamine (meth) addiction is a prevalent health concern worldwide,
yet remains without approved pharmacological treatments. Preclinical evidence
suggests that oxytocin may decrease relapse, but the neuronal underpinnings
driving this effect remain unknown. Here we investigate whether
oxytocin’s effect is dependent on presynaptic glutamatergic regulation
in the nucleus accumbens core (NAcore) by blocking metabotropic glutamate
receptors 2/3 (mGluR2/3). Male and female Sprague-Dawley rats self-administered
meth or sucrose on an escalating fixed ratio, followed by extinction and
cue-induced reinstatement sessions. Reinstatement tests consisted of systemic
(Experiment 1) or site-specific application of the drugs into the NAcore
(Experiments 2 and 3). Before reinstatement sessions, rats received LY341495, an
mGluR2/3 antagonist, or its vehicle followed by a second infusion/injection of
oxytocin or saline. As expected, both males and females reinstated lever
pressing to meth associated cues, and LY341495 alone did not impact this
behavior. Oxytocin injected systemically or infused into the NAcore decreased
cued meth seeking. Importantly, combined LY341495 and oxytocin administration
restored meth cued reinstatement. Interestingly, neither oxytocin nor LY341495
impacted sucrose-cued reinstatement, suggesting distinct mechanisms between meth
and sucrose. These findings were consistent between males and females. Overall,
we report that oxytocin reduced responding to meth-associated cues and blocking
presynaptic mGluR2/3 reversed this effect. Further, oxytocin’s effects
were specific to meth cues as NAcore oxytocin was without an effect on sucrose
cued reinstatement. Results are discussed in terms of oxytocin receptor
localization in the NAcore and modulation of presynaptic regulation of glutamate
in response to drug associated cues.